Found: 22
Select item for more details and to access through your institution.
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3065, doi. 10.1093/rheumatology/kead620
- By:
- Publication type:
- Article
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3033, doi. 10.1093/rheumatology/kead543
- By:
- Publication type:
- Article
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04075-0
- By:
- Publication type:
- Article
Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7399, doi. 10.3390/ijms24087399
- By:
- Publication type:
- Article
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01360-w
- By:
- Publication type:
- Article
Hydrogen sulfide donor NaHS causes bronchitis with enhanced respiratory secretion in rats.
- Published in:
- Journal of Toxicological Sciences, 2019, v. 44, n. 2, p. 107, doi. 10.2131/jts.44.107
- By:
- Publication type:
- Article
The Therapeutic Efficacy of Abatacept for Rheumatoid Arthritis-Associated Interstitial Lung Disease: Insights from a 12-Month Trial Using Semi-Quantitative Chest High-Resolution Computed Tomography Imaging.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 19, p. 5871, doi. 10.3390/jcm13195871
- By:
- Publication type:
- Article
Efficacy of abatacept tapering therapy for sustained remission in patients with rheumatoid arthritis: Prospective single‐center study.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 1, p. 81, doi. 10.1111/1756-185X.13384
- By:
- Publication type:
- Article
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 7, p. 2673, doi. 10.1007/s10067-021-05609-7
- By:
- Publication type:
- Article
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2418, doi. 10.1093/rheumatology/keae265
- By:
- Publication type:
- Article
Periodontal pathogens participate in synovitis in patients with rheumatoid arthritis in clinical remission: a retrospective case-control study.
- Published in:
- Rheumatology, 2015, v. 54, n. 12, p. 2257, doi. 10.1093/rheumatology/kev274
- By:
- Publication type:
- Article
Hypothyroidism‐induced hypermagnesemia with a small dose of magnesium.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion from hepatocytes and is mitigated by GYY4137.
- Published in:
- Journal of Toxicologic Pathology, 2019, v. 32, n. 4, p. 305, doi. 10.1293/tox.2019-0030
- By:
- Publication type:
- Article
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 928, doi. 10.1093/mr/roac115
- By:
- Publication type:
- Article
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 4, p. 834, doi. 10.1093/mr/roab043
- By:
- Publication type:
- Article
The addition of iguratimod can reduce methotrexate dose in rheumatoid arthritis with clinical remission.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 1, p. 68, doi. 10.1080/14397595.2021.1892945
- By:
- Publication type:
- Article
Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 4, p. 809, doi. 10.1080/14397595.2020.1829342
- By:
- Publication type:
- Article
Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 2, p. 227, doi. 10.1080/14397595.2017.1336865
- By:
- Publication type:
- Article
Gastrointestinal involvement at the onset of granulomatosis with polyangiitis: A case report.
- Published in:
- Modern Rheumatology, 2017, v. 27, n. 1, p. 162, doi. 10.3109/14397595.2014.954742
- By:
- Publication type:
- Article
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 5, p. 791, doi. 10.3109/s10165-011-0585-6
- By:
- Publication type:
- Article
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
- Published in:
- PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0202601
- By:
- Publication type:
- Article